Literature DB >> 8684486

A non-muscle myosin required for embryonic polarity in Caenorhabditis elegans.

S Guo1, K J Kemphues.   

Abstract

Daughter cells with distinct fates can arise through intrinsically asymmetrical divisions. Before such divisions, factors crucial for determining cell fates become asymmetrically localized in the mother cell. In Caenorhabditis elegans, PAR proteins are required for the early asymmetrical divisions that establish embryonic polarity, and are asymmetrically localized in early blastomeres, although the mechanism of their distribution is not known. Here we report the identification in C. elegans of nonmuscle myosin II heavy chain (designated NMY-2) by means of its interaction with the PAR-1 protein, a putative Ser/Thr protein kinase. Furthermore, injections of nmy-2 antisense RNA into ovaries of adult worms cause embryonic partitioning defects and lead to mislocalization of PAR proteins. We therefore conclude the NMY-2 is required for establishing cellular polarity in C. elegans embryos.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8684486     DOI: 10.1038/382455a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  73 in total

1.  Multiple subunits of the Caenorhabditis elegans anaphase-promoting complex are required for chromosome segregation during meiosis I.

Authors:  Edward S Davis; Lucia Wille; Barry A Chestnut; Penny L Sadler; Diane C Shakes; Andy Golden
Journal:  Genetics       Date:  2002-02       Impact factor: 4.562

2.  Polarization of the C. elegans zygote proceeds via distinct establishment and maintenance phases.

Authors:  Adrian A Cuenca; Aaron Schetter; Donato Aceto; Kenneth Kemphues; Geraldine Seydoux
Journal:  Development       Date:  2003-04       Impact factor: 6.868

3.  Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9.

Authors:  A K Lalwani; J A Goldstein; M J Kelley; W Luxford; C M Castelein; A N Mhatre
Journal:  Am J Hum Genet       Date:  2000-10-09       Impact factor: 11.025

4.  Distinct requirements for somatic and germline expression of a generally expressed Caernorhabditis elegans gene.

Authors:  W G Kelly; S Xu; M K Montgomery; A Fire
Journal:  Genetics       Date:  1997-05       Impact factor: 4.562

5.  Isolation of actin-associated proteins from Caenorhabditis elegans oocytes and their localization in the early embryo.

Authors:  R V Aroian; C Field; G Pruliere; C Kenyon; B M Alberts
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

6.  Involvement of the actin cytoskeleton and homotypic membrane fusion in ER dynamics in Caenorhabditis elegans.

Authors:  Dmitry Poteryaev; Jayne M Squirrell; Jay M Campbell; John G White; Anne Spang
Journal:  Mol Biol Cell       Date:  2005-02-16       Impact factor: 4.138

7.  Solution structure of the kinase-associated domain 1 of mouse microtubule-associated protein/microtubule affinity-regulating kinase 3.

Authors:  Naoya Tochio; Seizo Koshiba; Naohiro Kobayashi; Makoto Inoue; Takashi Yabuki; Masaaki Aoki; Eiko Seki; Takayoshi Matsuda; Yasuko Tomo; Yoko Motoda; Atsuo Kobayashi; Akiko Tanaka; Yoshihide Hayashizaki; Takaho Terada; Mikako Shirouzu; Takanori Kigawa; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

8.  Role of phosphatidylinositol-4-phosphate 5' kinase (ppk-1) in ovulation of Caenorhabditis elegans.

Authors:  Xiaojian Xu; Haisu Guo; Diane L Wycuff; Myeongwoo Lee
Journal:  Exp Cell Res       Date:  2007-03-24       Impact factor: 3.905

9.  Caenorhabditis elegans unc-82 encodes a serine/threonine kinase important for myosin filament organization in muscle during growth.

Authors:  Pamela E Hoppe; Johnnie Chau; Kelly A Flanagan; April R Reedy; Lawrence A Schriefer
Journal:  Genetics       Date:  2009-11-09       Impact factor: 4.562

10.  NMY-2 maintains cellular asymmetry and cell boundaries, and promotes a SRC-dependent asymmetric cell division.

Authors:  Ji Liu; Lisa L Maduzia; Masaki Shirayama; Craig C Mello
Journal:  Dev Biol       Date:  2010-01-06       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.